Pancreatic Cancer: The Deadliest and Most Elusive Cancer

Pancreatic cancer is recognized as one of the most lethal malignancies, defined by rapid progression, limited treatment options, and a tendency for late diagnosis.

Reporting from Nieuwsblad describes the disease as the sneakiest and deadliest of all cancers, noting that there is often much we unfortunately cannot do against it.

Global and National Impact

According to the World Cancer Report, pancreatic cancer is the seventh most common cause of cancer-related mortality worldwide.

The disease carries a low overall 5-year survival rate of 9%.

In the United States, the impact is significant. Estimates for 2025 indicate that 67,440 Americans will be diagnosed with pancreatic cancer, and more than 51,980 will die from the disease.

Types and Progression

The vast majority of cases fall under a single classification. Infiltrating pancreatic ductal adenocarcinoma is the most common type, accounting for more than 90% of pancreatic cancer cases.

The malignancy is characterized by how quickly it advances. Because it often progresses rapidly and is frequently diagnosed at a late stage, medical options for intervention are often limited.

Factors Influencing Prognosis

The long-term outlook for patients depends on several clinical factors present at the time of diagnosis. According to Johns Hopkins Medicine, the prognosis is influenced by:

• The size and type of the tumor.
• Whether lymph nodes are involved.
• The degree of metastasis, which refers to how far the cancer has spread.

These variables determine the extent of the disease and the potential for effective treatment.